Building Blocks

<p>Versatile small molecule scaffold</p>

<p>Pyrazolo[1,5-a]pyridin-4-ol is a heteroaromatic compound that acts as an inhibitor of phosphodiesterase (PDE). It prevents the breakdown of cyclic nucleotides and thus leads to increased levels of cAMP and cGMP. Pyrazolo[1,5-a]pyridin-4-ol has been shown to have bronchodilatory activity in animal models. The drug also inhibits the production of inflammatory mediators such as prostaglandins by inhibiting cyclooxygenases. In addition, pyrazolo[1,5-a]pyridin-4-ol has been shown to be a potential PDE inhibitor replacement for the more commonly used PDE inhibitors such as sildenafil and tadalafil. However, due to its lack of stereochemistry and its bicyclic chemical structure, pyrazolo[1,5-a]</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-Methyl-1H-indole-4-carboxylic acid (2MICA) is a cyclic compound that is used in the synthesis of other compounds. It is obtained by reacting 2,3-dibromo-nitrobenzoic acid with sodium ethoxide in an alkaline solution. The yield of 2MICA can be increased by using catalytic acid anhydrides such as dimethyl sulphoxide or lactam. In the presence of reductive agents, 2MICA can be synthesized from the corresponding lactam or cyclised carboxylic acid.<br>2MICA reacts with sodium ethoxide to form a lactam and reduces 2-bromo-3-nitrobenzoic acid to yield 2MICA.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>5,5-Dicyclopropylimidazolidine-2,4-dione is an ammonium salt that has a strong antispasmodic effect. It is used to treat muscle spasms and other types of spasticity. 5,5-Dicyclopropylimidazolidine-2,4-dione also has an alkali metal (e.g., sodium) or alkali earth metal (e.g., magnesium) salt form that can be used for the treatment of cystitis, pyelonephritis, and other urinary tract infections. This compound is converted to the corresponding hydantoin derivative in vivo by hydrolysis of the ethoxide group. Hydantoins are related to the hydantoin class of nonsteroidal anti-inflammatory drugs (NSAIDs).</p>

<p>N-(4-Aminophenyl)azepane-1-carboxamide is an analytical reference material, which is a secondary metabolite of plants. It is isolated from the root of the plant Scoparia dulcis, and it has been shown to have a variety of bioactive effects. N-(4-Aminophenyl)azepane-1-carboxamide has been found to inhibit the growth of various cancer cells in vitro and in vivo. It also inhibits protein synthesis and has antioxidant properties.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>4,6,7-Trichloroquinoline is an anticancer drug that was first synthesized in the late 1950s. It is a type of 1,2-dihydroquinoline that has been modified by the addition of three chlorine groups. 4,6,7-Trichloroquinoline inhibits the growth of cancer cells by inducing DNA strand breaks and inhibiting DNA synthesis and protein synthesis. This drug also induces cell death through the release of reactive oxygen species. 4,6,7-Trichloroquinoline binds to tumor cells and inhibits their proliferation by binding to DNA molecules and preventing them from replicating. The hydrolysis process for this compound occurs in two steps: first it is hydrolyzed into diethylmalonate and ethoxymethylenemalonate; then it undergoes cyclization with condensation and decarboxylation to form a quinolinium salt.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

Versatile small molecule scaffold

<p>4-Bromo-1-hydroxynaphthalene-2-carboxylic acid (4BHN) is a spectroscopic compound that has been used as a radioligand to study the binding of dopamine and dopamine D3 receptors. This compound binds to the d3 receptor with high affinity and specificity, but it does not interact with the d1 or d2 receptors. 4BHN has been shown to act as an agonist at the dopamine D3 receptor. It also acts as an antagonist at the piperidine site of the dopamine D2 receptor. The effects of 4BHN are reversible, which means that it can be displaced by unlabeled 4BHN or other compounds that bind to the same site on the receptor. This technique is useful for studying drug interactions and for determining whether drugs have a subtype selectivity profile.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-Bromomethyl-1,3,5-trimethylbenzene is a semivolatile organic compound with a bromophenol functional group. It has been shown to react with malic acid and pyridine ring to form two isomers. The reaction rate of this compound is higher at lower temperatures than at higher temperatures. It has been shown to be a ligand that binds metal ions and reacts with them electrochemically. 2-Bromomethyl-1,3,5-trimethylbenzene has also been used as an intermediate in the synthesis of trisaccharide ligands for coordination chemistry studies.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>